Record growth masks margin squeeze from commodity volatility

Revenue ₹276.3 Cr (+120.6% YoY), PAT ₹15.0 Cr (+130.7% YoY) confirmed

8.55% Q1 FY27 vs 7.90% Q1 FY26: +65 bps YoY growth evident

EBITDA 8.18% vs 9.28% Q1 FY26 (YoY) and 10.19% Q4 FY26. FMCG margin up YoY, consolidated dragged by costs.

Prior guidance 7% by FY27; new guidance 6% for FY27. Q1 delivered 5.4%, below both targets.

Prior 7% by FY27 → new 6% for FY27. Management frames as Q1 cost impact, expects recovery H2. 100 bps step-down.

FMCG now 90.6% of revenue (up from 83% FY26). Strategic pivot on track; no change to long-term 90-92% target.

Reaffirmed despite Q1 margin miss. Management confident existing capacity sufficient; no CapEx needed beyond 2024 plans.

Dyes, chemicals, LABSA, fuel, PP spiked due to geopolitical tension. Textile hit hardest. Expect normalization by Q3-Q4.

FY27: INR 900-1,000 Cr revenue, 6% PAT margin (down from 7% prior). FY28: 15-20% growth, 0.75-1% margin improvement.

Currently 50-55% utilization. Expect 25-30% additional capacity utilization by FY28. Profit margin improvement tied to volume scale.

Q1 numbers weak but internally re-evaluated. Expect recovery by Q3. No demerger plans; textile small portion of revenue.

Current quarter will improve. Targeting 7% PAT by FY28; EBITDA will rise 2-2.5% from current level via capacity optimization.

Very optimistic; numbers very encouraging. Will close FY27 at INR 900-1,000 Cr. FY28 target reaffirmed and achievable.

Food business and soap segment will have higher contribution next 2 years. Both newly ramping, high-growth trajectory.

No current acquisition discussions. Open to lucrative proposals. Developing new food products within existing capacity; some may need CapEx.

Q1 at ₹276 Cr; FY27 implies mid-to-high 200s per quarter average. Range anchored and credible.

Implies FY28 ₹1,035-1,200 Cr. INR 1,000 Cr target emphasized as achievable with existing capacity only.

Requires disciplined capacity utilization ramp from 50-55% to 75-85%+ by FY28.

Downgraded from prior 7% target. Q1 at 5.4%; Q2-Q4 must average >6% for full-year 6%. Cost recovery timing uncertain.

Implies FY28 PAT margin 6.75-7%. Dependent on input cost normalization and utilization gains.

Q1 EBITDA 8.18%; +2-2.5% implies 10.2-10.7% by FY28. Requires cost stabilization and scale benefits.

Most capacity expansion completed (Roorkee Q4-Q1, Guwahati ramp-up). Focus now on utilization, not expansion.

LABSA, dyes, chemicals, PP, fuel prices spiked Q1. Geopolitical tension driving volatility. Textile hit hardest; FMCG also exposed. Management cites normalization hope but no hedge disclosed.

Recent capacity additions (Roorkee Q1, Guwahati ongoing) must ramp utilization 25-30% by FY28 to hit margin targets. No detail on demand trajectory or customer commitments to fill new capacity.

PAT margin target downgraded 100 bps (7% → 6% for FY27). Q1 delivered 5.4%, requiring Q2-Q4 average >6%. Cost normalization and utilization gains must materialize on schedule.

Textile segment underperformed Q1 (~10% of revenue). Exposed to dyes, chemicals, crude-linked costs. Management confident on Q3 recovery but no numbers provided.

90% of revenue is B2B manufacturing to unnamed customers (management withheld names). Customer base stated 200+, but concentration in top 3-5 likely high. Loss of major customer risks growth.